celecoxib has been researched along with Tongue Neoplasms in 19 studies
Tongue Neoplasms: Tumors or cancer of the TONGUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study is to determine the effect of Celecoxib administration, dietary or topical, on expression of Ki-67, c-erb-B2, bcl-2 and bax genes in rat tongue by the immunohistochemistry methods and also tdt-mediated dupt-biotin nick end labeling assay in order to explore their role in malignant transformation and the proliferation rate, apoptosis rate in tongue squamous cell carcinoma." | 7.75 | Effect of dietary and topical Celecoxib on expression of bcl-2, bax, c-erb-B2 and Ki67 in carcinogen-induced tongue carcinoma in rat. ( Abbasi, MM; Aydemir, I; Dustar, Y; Javadzadeh, BY; Kalati, FA; Khaki, AA; Rad, JS; Roshangar, L; Sohrabi, M; Tuglu, IM; Vatansever, S, 2009) |
| "The aim of the study is to determine the effect of Celecoxib administration, dietary or topical, on expression of Ki-67, c-erb-B2, bcl-2 and bax genes in rat tongue by the immunohistochemistry methods and also tdt-mediated dupt-biotin nick end labeling assay in order to explore their role in malignant transformation and the proliferation rate, apoptosis rate in tongue squamous cell carcinoma." | 3.75 | Effect of dietary and topical Celecoxib on expression of bcl-2, bax, c-erb-B2 and Ki67 in carcinogen-induced tongue carcinoma in rat. ( Abbasi, MM; Aydemir, I; Dustar, Y; Javadzadeh, BY; Kalati, FA; Khaki, AA; Rad, JS; Roshangar, L; Sohrabi, M; Tuglu, IM; Vatansever, S, 2009) |
| "The celecoxib treatment decreased such rats to 0, 0, 0, and 13." | 1.51 | Effect of celecoxib on protein expression of FAK and Cx43 in DMBA induced rat tongue carcinoma cells. ( Guo, B; Li, YS; Shan, BZ; Sun, XF, 2019) |
| "Human tongue squamous cell carcinoma tumor cells Tca8113 and a mouse model with Tca8113 cells were used to study the growth inhibition of cisplatin enhanced by celecoxib." | 1.36 | Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinoma in vivo and in vitro. ( Ding, YQ; Li, WZ; Li, ZG; Wang, XY; Zhang, JH, 2010) |
| "Celecoxib could inhibit PGE2 production of Tca8113 cell in a dose-dependent manner, down-regulate MMP-2 secretion of Tca8113 cell, and at the same time significantly inhibit invasion and adhesion ability of these cells." | 1.36 | Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression. ( Huo, QJ; Li, WZ; Wang, XY; Xu, F, 2010) |
| "Celecoxib could notably enhance the inhibitory effect of bleomycin on Tca8113 cells by blocking cell cycle progress and thus resulting in the increasing G(0)/G(1) cells [(60." | 1.35 | [Celecoxib enhances the lethal effects of bleomycin in human tongue squamous carcinoma cell line Tca8113]. ( Ding, YQ; Li, WZ; Li, ZG; Wang, XY; Zhang, JH, 2009) |
| "Celecoxib treatment for 24 h also resulted in significantly decreased adhesion of Tca8113 cells on Fn-coated surface in a dose-dependent manner." | 1.35 | [Inhibitory effects of COX-2 inhibitor on migration of human tongue squamous cell carcinoma Tca8113 cells]. ( Huo, QJ; Li, WZ, 2009) |
| "Esophageal and tongue cancers have both been associated with dietary zinc deficiency (ZD), and cyclooxygenase (COX-2) is often overexpressed in these cancers." | 1.33 | Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats. ( Farber, JL; Fong, LY; Jiang, Y; Zhang, L, 2005) |
| "Celecoxib is a selective inhibitor of cyclooxygenase-2 (COX-2) that is a critical factor in carcinogenesis, but precise mechanism of its action remains to be elucidated." | 1.33 | Heterogeneous nuclear ribonuclear protein C is increased in the celecoxib-induced growth inhibition of human oral squamous cell carcinoma. ( Kim, J; Kim, SH; Kwark, YE; Lee, EJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shan, BZ | 1 |
| Guo, B | 1 |
| Li, YS | 1 |
| Sun, XF | 1 |
| Lee, DY | 1 |
| Lim, JH | 1 |
| Kim, YJ | 1 |
| Kim, SD | 1 |
| Park, SW | 1 |
| Kwon, SK | 1 |
| Hah, JH | 1 |
| Kwon, TK | 1 |
| Kim, KH | 1 |
| Kim, YH | 1 |
| Sung, MW | 1 |
| Becker, MR | 1 |
| Gaiser, T | 1 |
| Li, WZ | 7 |
| Wang, XY | 6 |
| Ding, YQ | 4 |
| Li, ZG | 2 |
| Zhang, JH | 2 |
| Sohrabi, M | 2 |
| Kalati, FA | 1 |
| Vatansever, S | 2 |
| Abbasi, MM | 2 |
| Roshangar, L | 2 |
| Khaki, AA | 2 |
| Tuglu, IM | 1 |
| Aydemir, I | 1 |
| Dustar, Y | 2 |
| Javadzadeh, BY | 1 |
| Rad, JS | 1 |
| Huo, QJ | 3 |
| Soleimani, J | 1 |
| Arbabi, F | 1 |
| Javadzadeh, Y | 1 |
| Xu, F | 1 |
| Conde, N | 1 |
| Cruz, O | 1 |
| Albert, A | 1 |
| Mora, J | 1 |
| Fong, LY | 2 |
| Zhang, L | 1 |
| Jiang, Y | 2 |
| Farber, JL | 2 |
| Park, K | 1 |
| Yang, JH | 1 |
| Choi, Y | 1 |
| Lee, C | 1 |
| Kim, SY | 1 |
| Byun, Y | 1 |
| Lee, EJ | 2 |
| Kim, SH | 1 |
| Kwark, YE | 1 |
| Kim, J | 2 |
| Kwak, YE | 1 |
| Jeon, NK | 1 |
| Scheper, MA | 1 |
| Nikitakis, NG | 1 |
| Sauk, JJ | 1 |
| Riley, M | 1 |
| Liu, X | 1 |
| Smalley, KJ | 1 |
| Guttridge, DC | 1 |
19 other studies available for celecoxib and Tongue Neoplasms
| Article | Year |
|---|---|
Effect of celecoxib on protein expression of FAK and Cx43 in DMBA induced rat tongue carcinoma cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Celecoxi | 2019 |
Effect of Celecoxib on Survival of Mobile Tongue Cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease-Free Survival | 2015 |
Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Celecoxib; Combined Modality Therapy | 2009 |
[Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
Topics: Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors | 2009 |
[Celecoxib enhances the lethal effects of bleomycin in human tongue squamous carcinoma cell line Tca8113].
Topics: Apoptosis; Bleomycin; Carcinoma, Squamous Cell; Celecoxib; Cell Cycle; Cell Line, Tumor; Cyclooxygen | 2009 |
Effect of dietary and topical Celecoxib on expression of bcl-2, bax, c-erb-B2 and Ki67 in carcinogen-induced tongue carcinoma in rat.
Topics: Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; bcl-2-Associated X Protein; Carcinoge | 2009 |
[Inhibitory effects of COX-2 inhibitor on migration of human tongue squamous cell carcinoma Tca8113 cells].
Topics: Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2 Inhibitors; H | 2009 |
Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinoma in vivo and in vitro.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Celecoxib; Cell L | 2010 |
[Celecoxib induces cell cycle arrest and apoptosis in human tongue squamous carcinoma cell line Tca8113].
Topics: Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Cycle; Cell Line, Tumor; Cyclooxygenase 2 Inhib | 2010 |
The effect of dietary and topical celecoxib on 4-nitroquinoline-1-oxide-induced lingual epithelium alternations in rat.
Topics: 4-Nitroquinoline-1-oxide; Administration, Topical; Analysis of Variance; Animals; Celecoxib; Cycloox | 2009 |
Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.
Topics: Carcinoma, Squamous Cell; Celecoxib; Cell Adhesion; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygena | 2010 |
[Effect of cyclooxygenase-2 inhibitor on expression of matrix metalloproteinase-2 and invasion of tongue squamous cell carcinoma cell line Tca8113].
Topics: Carcinoma, Squamous Cell; Celecoxib; Cell Adhesion; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; H | 2010 |
Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Celecoxib; Child, Preschool | 2011 |
Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
Topics: 4-Nitroquinoline-1-oxide; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Squamous Ce | 2005 |
Chemoprevention of 4-NQO-induced oral carcinogenesis by co-administration of all-trans retinoic acid loaded microspheres and celecoxib.
Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Celecoxib; Cyc | 2005 |
Heterogeneous nuclear ribonuclear protein C is increased in the celecoxib-induced growth inhibition of human oral squamous cell carcinoma.
Topics: Actins; Aged; Carcinoma, Squamous Cell; Celecoxib; Cell Cycle; Cell Line, Tumor; Cell Proliferation; | 2006 |
The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
Topics: Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibito | 2007 |
Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Division; Ce | 2007 |
Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibi | 2008 |